Columvi (Glofitamab)

**Product type:** Human Prescription Drug

**Active ingredient:** GLOFITAMAB

**Strength:** 10 mg/10mL

**Dosage form:** Concentrate

**Route:** Intravenous

**Labeler:** Genentech, Inc.

**Marketing category:** BLA (BLA761309)

**Pharmacologic class:** Bispecific CD20-directed CD3 T Cell Engager [EPC], CD20-directed Antibody Interactions [MoA], CD3 Receptor Agonists [MoA], CD3-directed Antibody Interactions [MoA], Cytochrome P450 Inhibitors [MoA], Increased Cytokine Activity [PE]